Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1998
06/25/1998CA2275213A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
06/25/1998CA2273288A1 Method of treating or inhibiting neutropenia
06/25/1998CA2272853A1 Use of peptides for improving the incorporation of skin grafts
06/24/1998EP0849256A1 Amide compounds and use of the same
06/24/1998EP0848955A1 Anti-stress agent for animals comprising an ascorbic acid derivative
06/24/1998EP0848951A1 Use of acetylcysteine for the manufacture of a medicament for the treatment of chronic ulcers
06/24/1998EP0848706A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists
06/24/1998EP0848705A1 Crystalline r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
06/24/1998EP0848704A1 Form iii crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
06/24/1998EP0848696A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
06/24/1998EP0848613A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof
06/24/1998EP0700380B1 N-alkylthio polyamine derivatives as radioprotective agents
06/24/1998EP0680468B1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation
06/24/1998EP0679161B1 Thiazolidine derivatives, preparation thereof and drugs containing same
06/24/1998CN1185786A Sugar-modified cytostatics
06/24/1998CN1185742A Protein kinase c inhibitors
06/24/1998CN1185734A Method of altering the contents of eggs
06/24/1998CN1185435A Sulfamide-substituted compound, preparation method, and medicinal preparation containing same
06/24/1998CN1185337A Multi-effect oral liquor-Tuishaoling for bringing down fever and preparation method thereof
06/24/1998CN1185319A Tumor-blood-vessel growth inhibitor and medicinal composition
06/23/1998US5770735 Neurokinin receptor antagonists
06/23/1998US5770732 Stable non-peptidal compounds which can inhibit the chemical activity of peptides and enzymes
06/23/1998US5770624 Inhibitors of tumor necrosis factor alpha and matrix degrading metalloproteinease activity
06/23/1998US5770617 Terbenzimidazoles useful as antifungal agents
06/23/1998US5770612 Administering substituted benzothiophenes, solvates or salts along with analgesics, diuratics or antihistaminesalong with
06/23/1998US5770611 Indole derivatives as 5HT1 -like agonists
06/23/1998US5770610 Melatonin agonists for use in the treatment of benign prostatic hyperplasia (BPH)
06/23/1998US5770599 Quinazoline derivatives
06/23/1998US5770586 Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism amd methods of treating and preventing dental calculus and plaque
06/23/1998US5770575 Nipecotic acid derivatives as antithrombotic compounds
06/23/1998US5770574 Long-chain alkylamides of amino acids and peptides with anti-proliferative and anti-inflammatory properties
06/23/1998US5770571 Method and agents for inhibiting protein aging
06/23/1998US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide
06/23/1998US5770565 Peptides for reducing or inhibiting bone resorption
06/23/1998US5770403 Genetically engineered nucleic acid coding for antibodies which bind to and block interleukins
06/23/1998US5770386 Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent
06/23/1998US5770384 Method for determining compound interaction with E2 binding proteins
06/23/1998US5770209 Acceleration of wound healing using connective tissue growth factor
06/23/1998US5770195 Antitumor
06/23/1998CA2176506C Substituted oxindoles
06/23/1998CA2096318C 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
06/23/1998CA2008739C Compositions and method for the treatment of disease
06/23/1998CA1339925C Affined heparinic oligosaccharides for cell growth factors
06/20/1998CA2225273A1 Vitronectin receptor antagonists, their preparation and their use
06/20/1998CA2225267A1 Vitronectin receptor antagonists, their preparation and their use
06/20/1998CA2225202A1 Compositions for the treatment of chronic wounds
06/18/1998WO1998026070A1 Bone stimulating factor
06/18/1998WO1998026069A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998026068A1 Human apoptosis-related calcium-binding protein
06/18/1998WO1998026062A2 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
06/18/1998WO1998026052A1 Tryparedoxin peroxidase
06/18/1998WO1998026047A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998025965A2 Peptides and compounds that bind to the thrombopoietin receptor
06/18/1998WO1998025956A2 Human gtp-binding proteins
06/18/1998WO1998025951A1 Inhibitors of peptide binding to mhc class ii proteins
06/18/1998WO1998025925A1 Pyrrole derivatives, their preparation and pharmaceutical compositions containing them
06/18/1998WO1998025919A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
06/18/1998WO1998025914A1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate
06/18/1998WO1998025901A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998WO1998025899A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
06/18/1998WO1998025898A1 Seco precursors of cyclopropylindolines and their use as prodrugs
06/18/1998WO1998025895A1 Inhibitors of the enzymatic activity of psa
06/18/1998WO1998025883A1 Ketobenzamides as calpain inhibitors
06/18/1998WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
06/18/1998WO1998025636A1 Stomach submucosa derived tissue graft
06/18/1998WO1998025634A1 Serum-derived factor inducing cell differentiation and medical uses thereof
06/18/1998WO1998025619A1 Novel compounds
06/18/1998WO1998025609A1 PYRROLES AS sPLA2 INHIBITORS
06/18/1998WO1998025606A1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
06/18/1998WO1998025601A1 Fibrinogen receptor antagonists
06/18/1998WO1998025593A2 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kB FACTOR
06/18/1998WO1998018477A3 Pharmaceutical compositions containing lamivudine and zidovudine
06/18/1998WO1998018430A3 P2y receptor antagonists
06/18/1998WO1998016523A3 Selective factor xa inhibitors
06/18/1998WO1998005361A3 Long-acting drugs and pharmaceutical compositions comprising them
06/18/1998CA2275177A1 Tryparedoxin peroxidase
06/18/1998CA2274958A1 Inhibitors of the enzymatic activity of psa
06/18/1998CA2274898A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
06/18/1998CA2274739A1 Human apoptosis-related calcium-binding protein
06/18/1998CA2274735A1 Human gtp-binding proteins
06/18/1998CA2274682A1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate
06/18/1998CA2274655A1 Novel compounds
06/18/1998CA2274571A1 Pyrroles as spla2 inhibitors
06/18/1998CA2274500A1 Bone stimulating factor
06/18/1998CA2274029A1 Fibrinogen receptor antagonists
06/18/1998CA2273988A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
06/18/1998CA2272952A1 Seco precursors of cyclopropylindolines and their use as prodrugs
06/17/1998EP0848063A2 Nucleic acid constructs containing hybrid promotors for use in gene therapy
06/17/1998EP0847999A1 N-benzylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them
06/17/1998EP0847996A1 Sulfonamide substituted compounds as K-channel blockers
06/17/1998EP0847400A1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
06/17/1998EP0847281A1 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases
06/17/1998EP0847278A1 Analogs of parathyroid hormone
06/17/1998EP0847277A1 Treatment of ocular inflammatory conditions with interleukin-10
06/17/1998EP0847239A2 Improved method for controlling ectoparasites
06/17/1998EP0745124B1 Mammalian cell cycle protein
06/17/1998EP0714389B1 Amide and urea derivatives as 5ht1d receptor antagonists
06/17/1998EP0689549B1 New urea derivates, their preparation and their use
06/17/1998EP0666847B1 Tryptamine analogs with 5-ht1d selectivity
1 ... 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 ... 1564